Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cellulitis | 9 | 2020 | 206 | 2.860 |
Why?
|
| Human papillomavirus 16 | 5 | 2014 | 262 | 0.730 |
Why?
|
| Skin | 6 | 2020 | 4364 | 0.620 |
Why?
|
| Lidocaine | 1 | 2018 | 544 | 0.520 |
Why?
|
| Neutrophils | 4 | 2021 | 3719 | 0.510 |
Why?
|
| Hyperthermia, Induced | 1 | 2018 | 403 | 0.510 |
Why?
|
| Langerhans Cells | 5 | 2015 | 173 | 0.510 |
Why?
|
| Staphylococcal Infections | 2 | 2019 | 1400 | 0.440 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2019 | 828 | 0.430 |
Why?
|
| Anti-Bacterial Agents | 6 | 2020 | 7181 | 0.400 |
Why?
|
| Alphapapillomavirus | 1 | 2013 | 221 | 0.360 |
Why?
|
| Virus Internalization | 2 | 2014 | 501 | 0.360 |
Why?
|
| Papillomavirus Infections | 6 | 2014 | 1587 | 0.350 |
Why?
|
| Receptors, Virus | 1 | 2013 | 648 | 0.350 |
Why?
|
| Home Care Services | 2 | 2020 | 606 | 0.230 |
Why?
|
| Annexin A2 | 2 | 2014 | 44 | 0.230 |
Why?
|
| Diagnostic Errors | 3 | 2019 | 1257 | 0.210 |
Why?
|
| Oncogene Proteins, Viral | 3 | 2014 | 362 | 0.200 |
Why?
|
| Antigens, Neoplasm | 2 | 2008 | 1988 | 0.200 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 15540 | 0.180 |
Why?
|
| Capsid Proteins | 3 | 2014 | 479 | 0.180 |
Why?
|
| Luminescence | 1 | 2020 | 137 | 0.170 |
Why?
|
| Borrelia burgdorferi | 1 | 2021 | 180 | 0.170 |
Why?
|
| Papillomaviridae | 3 | 2015 | 1119 | 0.170 |
Why?
|
| Skin Neoplasms | 1 | 2018 | 5686 | 0.170 |
Why?
|
| Dermatology | 2 | 2019 | 872 | 0.160 |
Why?
|
| Skin Temperature | 1 | 2017 | 93 | 0.150 |
Why?
|
| Membrane Glycoproteins | 1 | 2008 | 3768 | 0.150 |
Why?
|
| Remote Consultation | 1 | 2019 | 238 | 0.140 |
Why?
|
| Neoplasm Proteins | 1 | 2008 | 3703 | 0.140 |
Why?
|
| Leukocytosis | 1 | 2017 | 247 | 0.130 |
Why?
|
| Lyme Disease | 1 | 2021 | 621 | 0.130 |
Why?
|
| Churg-Strauss Syndrome | 1 | 2015 | 70 | 0.120 |
Why?
|
| Cyclosporine | 1 | 2017 | 786 | 0.120 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2019 | 428 | 0.120 |
Why?
|
| Tachycardia | 1 | 2017 | 619 | 0.120 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 2017 | 280 | 0.120 |
Why?
|
| Bronchiectasis | 1 | 2015 | 128 | 0.120 |
Why?
|
| Foot Diseases | 1 | 2015 | 143 | 0.120 |
Why?
|
| Cost Savings | 1 | 2019 | 926 | 0.110 |
Why?
|
| Cell Cycle | 2 | 2018 | 2967 | 0.110 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2013 | 118 | 0.110 |
Why?
|
| Virion | 1 | 2015 | 433 | 0.110 |
Why?
|
| Dermatitis, Atopic | 1 | 2019 | 654 | 0.110 |
Why?
|
| Streptococcal Infections | 1 | 2016 | 638 | 0.100 |
Why?
|
| Interdisciplinary Communication | 1 | 2018 | 950 | 0.100 |
Why?
|
| S100 Proteins | 1 | 2012 | 259 | 0.100 |
Why?
|
| Leg | 1 | 2017 | 1116 | 0.100 |
Why?
|
| Molecular Biology | 1 | 2015 | 596 | 0.090 |
Why?
|
| Immunosuppressive Agents | 2 | 2017 | 4149 | 0.090 |
Why?
|
| Staphylococcus aureus | 1 | 2019 | 1451 | 0.090 |
Why?
|
| Physician's Role | 1 | 2018 | 943 | 0.090 |
Why?
|
| Emergencies | 1 | 2017 | 1170 | 0.090 |
Why?
|
| Bacteremia | 1 | 2017 | 962 | 0.090 |
Why?
|
| Drug Discovery | 1 | 2018 | 1058 | 0.090 |
Why?
|
| Decision Support Techniques | 1 | 2019 | 1956 | 0.080 |
Why?
|
| Humans | 27 | 2021 | 744343 | 0.080 |
Why?
|
| Toll-Like Receptor 8 | 1 | 2009 | 90 | 0.080 |
Why?
|
| Cell Survival | 1 | 2018 | 5882 | 0.080 |
Why?
|
| Diagnosis, Differential | 3 | 2019 | 12959 | 0.080 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2009 | 172 | 0.080 |
Why?
|
| GPI-Linked Proteins | 1 | 2008 | 434 | 0.070 |
Why?
|
| Protein Multimerization | 1 | 2012 | 970 | 0.070 |
Why?
|
| Immune Tolerance | 2 | 2014 | 2258 | 0.070 |
Why?
|
| Down-Regulation | 1 | 2014 | 3002 | 0.070 |
Why?
|
| Societies, Medical | 1 | 2018 | 3743 | 0.070 |
Why?
|
| Prostatic Neoplasms | 1 | 2008 | 11124 | 0.070 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2009 | 880 | 0.060 |
Why?
|
| Cytokines | 4 | 2015 | 7322 | 0.060 |
Why?
|
| Models, Theoretical | 1 | 2017 | 3589 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 15076 | 0.060 |
Why?
|
| Cell Line | 1 | 2018 | 15997 | 0.060 |
Why?
|
| Patient Preference | 2 | 2020 | 890 | 0.060 |
Why?
|
| Immunotherapy | 2 | 2008 | 4445 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2018 | 3309 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 16689 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 14722 | 0.050 |
Why?
|
| Complement C5 | 1 | 2021 | 112 | 0.050 |
Why?
|
| Risk Factors | 2 | 2019 | 72290 | 0.050 |
Why?
|
| Cancer Vaccines | 1 | 2008 | 1023 | 0.050 |
Why?
|
| Age Factors | 1 | 2017 | 18370 | 0.040 |
Why?
|
| Emollients | 1 | 2019 | 34 | 0.040 |
Why?
|
| Male | 10 | 2019 | 350118 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 7659 | 0.040 |
Why?
|
| Skin Diseases, Infectious | 1 | 2019 | 74 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2009 | 2725 | 0.040 |
Why?
|
| Luminescent Measurements | 1 | 2020 | 405 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2017 | 41006 | 0.040 |
Why?
|
| Hospitals, Urban | 1 | 2019 | 499 | 0.040 |
Why?
|
| Hospitals | 2 | 2020 | 3952 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 25043 | 0.030 |
Why?
|
| Female | 9 | 2019 | 380194 | 0.030 |
Why?
|
| Microfluidics | 1 | 2021 | 662 | 0.030 |
Why?
|
| Length of Stay | 2 | 2019 | 6309 | 0.030 |
Why?
|
| Standard of Care | 1 | 2017 | 564 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2019 | 1539 | 0.030 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2015 | 288 | 0.030 |
Why?
|
| Animals | 4 | 2020 | 168757 | 0.030 |
Why?
|
| HIV Infections | 1 | 2019 | 16718 | 0.030 |
Why?
|
| Cell Movement | 2 | 2019 | 5217 | 0.030 |
Why?
|
| Diffusion of Innovation | 1 | 2018 | 725 | 0.030 |
Why?
|
| Aged | 4 | 2019 | 163280 | 0.030 |
Why?
|
| Hospital Costs | 1 | 2019 | 985 | 0.030 |
Why?
|
| Patient Admission | 1 | 2019 | 1380 | 0.030 |
Why?
|
| Middle Aged | 4 | 2019 | 213383 | 0.030 |
Why?
|
| Protein Structure, Quaternary | 1 | 2012 | 436 | 0.020 |
Why?
|
| Point-of-Care Systems | 1 | 2020 | 1177 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2009 | 10180 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2018 | 1504 | 0.020 |
Why?
|
| Exanthema | 1 | 2015 | 501 | 0.020 |
Why?
|
| Swine | 1 | 2020 | 5917 | 0.020 |
Why?
|
| Aminoquinolines | 1 | 2009 | 109 | 0.020 |
Why?
|
| Adult | 3 | 2019 | 214055 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2012 | 1801 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2014 | 1076 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 1655 | 0.020 |
Why?
|
| Biopsy | 1 | 2019 | 6756 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1997 | 1888 | 0.020 |
Why?
|
| Histones | 1 | 1997 | 2599 | 0.020 |
Why?
|
| Time Factors | 2 | 2019 | 40075 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2012 | 3128 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1997 | 2752 | 0.020 |
Why?
|
| Epitopes | 1 | 2012 | 2571 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 1997 | 3023 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2015 | 4217 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2015 | 3748 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2017 | 3528 | 0.020 |
Why?
|
| Boston | 1 | 2017 | 9313 | 0.020 |
Why?
|
| Quinolines | 1 | 2009 | 732 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 1 | 2009 | 1000 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2015 | 8436 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 3505 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2012 | 2866 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 2009 | 1607 | 0.010 |
Why?
|
| Immunocompromised Host | 1 | 2008 | 847 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 1997 | 7722 | 0.010 |
Why?
|
| Imidazoles | 1 | 2009 | 1206 | 0.010 |
Why?
|
| Logistic Models | 1 | 2017 | 13408 | 0.010 |
Why?
|
| Viral Vaccines | 1 | 2008 | 636 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2009 | 2216 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 1997 | 5853 | 0.010 |
Why?
|
| Peptides | 1 | 2014 | 4409 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2019 | 63114 | 0.010 |
Why?
|
| Papillomavirus Vaccines | 1 | 2008 | 491 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 2503 | 0.010 |
Why?
|
| Disease Progression | 1 | 2017 | 13284 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 13815 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2012 | 3690 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2009 | 2938 | 0.010 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2008 | 1270 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 18111 | 0.010 |
Why?
|
| Genotype | 1 | 2014 | 12951 | 0.010 |
Why?
|
| Neoplasms | 1 | 2008 | 21683 | 0.010 |
Why?
|
| Hemagglutinins | 1 | 1997 | 117 | 0.010 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2009 | 2020 | 0.010 |
Why?
|
| Lung | 1 | 2015 | 9856 | 0.010 |
Why?
|
| RNA, Fungal | 1 | 1997 | 164 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2019 | 40561 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1997 | 829 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1997 | 573 | 0.010 |
Why?
|
| Infant | 1 | 2017 | 35136 | 0.010 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 1997 | 502 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2009 | 19229 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 1997 | 1547 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 56430 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 8428 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 20129 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 1997 | 1072 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2019 | 77449 | 0.010 |
Why?
|
| Child | 1 | 2017 | 77709 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1997 | 3772 | 0.000 |
Why?
|
| Mutation | 1 | 2012 | 29786 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 2009 | 13695 | 0.000 |
Why?
|
| Promoter Regions, Genetic | 1 | 1997 | 5867 | 0.000 |
Why?
|
| Bacterial Proteins | 1 | 1997 | 3848 | 0.000 |
Why?
|
| Mice | 1 | 2008 | 81183 | 0.000 |
Why?
|
Concepts
(176)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(16)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_